DVAX vs MNDY · rev $277.2M vs P/E 32, rev $1.23B
Dynavax Technologies Corporation (DVAX) versus Monday.Com Ltd (MNDY) — a side-by-side from cached financials, not a winner call.
Dynavax Technologies Corporation (DVAX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Monday.Com Ltd (MNDY) is a software - application company listed on US.
Latest reported DVAX revenue for 2024-12-31 was $277.2M. Net income was $27.3M. Revenue was up 19.4% from 2023-12-31 to 2024-12-31. DVAX currently screens at market cap $1.82B.
Latest reported MNDY revenue for 2025-12-31 was $1.23B. Net income was $118.7M. Revenue was up 26.7% from 2024-12-31 to 2025-12-31. MNDY currently screens at market cap $3.79B and trailing P/E 32.1.
DVAX currently screens at market cap $1.82B. MNDY currently screens at market cap $3.79B and trailing P/E 32.1.
Not investment advice. Open the DVAX and MNDY stock pages for the full models.
Not investment advice.